共 50 条
- [45] Clinical and economic benefits of using next-generation sequencing (NGS) in the diagnostics of patients with non-small cell lung cancer with rare mutations [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (03): : 201 - 208
- [46] The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 2637 - 2646
- [48] Gene rearrangement detection by next-generation sequencing in patients with non-small cell lung carcinoma [J]. BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (02): : 127 - 132
- [49] Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer [J]. ONCOLOGIST, 2019, 24 (11): : E1070 - E1081